Clinical trial
A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of CJ-12420 in Patients With Non-erosive Reflux Disease
NCT02556021 is registered in ClinicalTrials.gov with HK inno.N Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Study to Evaluate the Efficacy and Safety of CJ-12420 in Patients With Non-erosive Reflux Disease
- Lead sponsor
- HK inno.N Corporation
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 22, 2015
- Completion date
- November 1, 2016
- Enrollment
- 324 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.